We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+9.54%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$109B
AUM Growth
+$10.1B
Cap. Flow
+$2.06B
Cap. Flow %
1.89%
Top 10 Hldgs %
23.41%
Holding
4,156
New
227
Increased
1,649
Reduced
1,885
Closed
242

Top Buys

Rank Stock Value
1
VOO icon
Vanguard S&P 500 ETF
VOO
+$169M
2
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$116M
3
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$87.5M
4
ABBV icon
AbbVie
ABBV
+$80.5M
5
JPM icon
JPMorgan Chase
JPM
+$79.3M

Top Sells

Rank Stock Value
1
IGM icon
iShares Expanded Tech Sector ETF
IGM
+$79.2M
2
CMCSA icon
Comcast
CMCSA
+$69.1M
3
CHNG
Change Healthcare Inc. Common Stock
CHNG
+$53.3M
4
META icon
Meta Platforms (Facebook)
META
+$48.1M
5
VZ icon
Verizon
VZ
+$41.8M

Sector Composition

Rank Sector Weight
1 Technology 12.51%
2 Healthcare 9.35%
3 Financials 9.21%
4 Industrials 6.82%
5 Consumer Discretionary 5.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HYFM icon
3576
Hydrofarm Holdings
HYFM
$8.58M
$128K ﹤0.01%
8,256
+7,028
+572% +$161K
NFNT.U
3577
DELISTED
Infinite Acquisition Corp. Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant
NFNT.U
$128K ﹤0.01%
12,500
– –
IFRX icon
3578
InflaRx
IFRX
$296M
$127K ﹤0.01%
41,123
-2,300
-5% -$5.86K
PBI icon
3579
Pitney Bowes
PBI
$2.28B
$127K ﹤0.01%
33,541
-5,995
-15% -$20.2K
TERN
3580
DELISTED
Terns Pharmaceuticals
TERN
$127K ﹤0.01%
+12,488
New +$83.1K
CFFN icon
3581
Capitol Federal Financial
CFFN
$1.09B
$127K ﹤0.01%
14,680
– –
MIN
3582
Aberdeen Intermediate Income Fund
MIN
$280M
$127K ﹤0.01%
45,977
+6,685
+17% +$18.7K
VGR
3583
DELISTED
Vector Group Ltd.
VGR
$126K ﹤0.01%
10,617
– –
PFLT icon
3584
PennantPark Floating Rate Capital
PFLT
$752M
$126K ﹤0.01%
11,453
+56
+0.5% +$614
NPCT icon
3585
Nuveen Core Plus Impact Fund
NPCT
$284M
$126K ﹤0.01%
+12,128
New +$127K
FOLD
3586
DELISTED
Amicus Therapeutics
FOLD
$125K ﹤0.01%
+10,273
New +$116K
EVGO icon
3587
EVgo
EVGO
$519M
$125K ﹤0.01%
27,957
-1,187
-4% -$7.67K
FINV
3588
FinVolution Group
FINV
$1.07B
$123K ﹤0.01%
24,876
-1,500
-6% -$7.05K
GLAD icon
3589
Gladstone Capital
GLAD
$452M
$123K ﹤0.01%
6,390
+250
+4% +$4.8K
JPM icon
3590
CALL
JPMorgan Chase
JPM
$965B
$122K ﹤0.01%
121,600
+18,000
+17% +$2.28M
SB icon
3591
Safe Bulkers
SB
$781M
$121K ﹤0.01%
41,543
+11,159
+37% +$30.9K
HNRG icon
3592
Hallador Energy
HNRG
$730M
$121K ﹤0.01%
+12,099
New +$99.6K
BGT icon
3593
BlackRock Floating Rate Income Trust
BGT
$329M
$120K ﹤0.01%
10,977
+33
+0.3% +$366
NETI
3594
DELISTED
Eneti Inc.
NETI
$119K ﹤0.01%
11,890
-8,982
-43% -$79.7K
MIXT
3595
DELISTED
MIX TELEMATICS LIMITED
MIXT
$119K ﹤0.01%
16,915
-4,318
-20% -$33.5K
BAK icon
3596
Braskem
BAK
$825M
$119K ﹤0.01%
+12,920
New +$144K
RUM icon
3597
RUM Group Inc
RUM
$3.74B
$119K ﹤0.01%
19,972
+6,140
+44% +$58.9K
DNMR
3598
DELISTED
Danimer Scientific, Inc.
DNMR
$118K ﹤0.01%
1,648
-658
-29% -$62.2K
GDXJ icon
3599
CALL
VanEck Junior Gold Miners ETF
GDXJ
$8.33B
$118K ﹤0.01%
40,600
-62,000
-60% -$2.04M
OPP
3600
RiverNorth/DoubleLine Strategic Opportunity Fund
OPP
$192M
$118K ﹤0.01%
13,720
-1,272
-8% -$11.5K
142 143
144
145 146

Similar funds

RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
PI
PEAK6 Investments Chicago, Illinois $44.8B AUM 19.99% 1-Year Est. Return
ECU
Eisler Capital (UK) London, United Kingdom $21.7B AUM 0.34% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
AA
Axiom Advisory San Diego, California $10.7B AUM 25.51% 1-Year Est. Return
SA
SpiderRock Advisors Wilimington, Delaware $6.29B AUM
WPL
Winder Pte Ltd Singapore $5.59B AUM 41.5% 1-Year Est. Return
ECU
Eisler Capital (US) New York $4.67B AUM 35.2% 1-Year Est. Return

Raymond James & Associates's Q4 2022 Portfolio in Review

As of Q4 2022, Raymond James & Associates held 4,156 positions worth $109B, up 10% from $98.8B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Raymond James & Associates's Q4 2022 filing shows 227 new, 1,649 increased, 1,885 reduced and 242 closed positions. Its largest new stake was Rentokil: 285,133 shares worth $8.78M. The largest sale was iShares Expanded Tech Sector ETF, an estimated $79.2M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 13% a quarter earlier, followed by Healthcare and Financials.

  • Raymond James & Associates's largest Q4 2022 buy was Rentokil: 285,133 shares worth $8.78M.
  • Raymond James & Associates added most to Vanguard S&P 500 ETF in Q4 2022, an estimated $169M increase.
  • Raymond James & Associates's biggest Q4 2022 reduction was iShares Expanded Tech Sector ETF, cutting an estimated $79.2M.
  • Raymond James & Associates fully exited Change Healthcare Inc. Common Stock in Q4 2022, selling an estimated $53.3M.
  • Raymond James & Associates's ten largest holdings make up 23% of its $109B portfolio in Q4 2022.
  • Raymond James & Associates opened 227 new positions and closed 242 in Q4 2022.
  • Raymond James & Associates's portfolio value rose 10% quarter-over-quarter to $109B.

Based on Raymond James & Associates's 13F filing for Q4 2022, filed 8 Feb 2023.